Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (251-260 of 311) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant ErythropoietinAlan F List, Zhuoxin Sun, Amit Verma, et al.
Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.
Communications Sustainability|February 12, 2026
Riparian vegetation reduces coastal turbidityHilary D Brumberg, Laura E Dee, Hikari Murayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Blood Advances|May 8, 2026
Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance)Wellington F Silva, Jun Yin, Michaela Liedtke, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignanciesPrithviraj Bose, Edward B Perkins, Connie Honeycut, et al.
Pageof 32

Showing results (251-260 of 311) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2021
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant ErythropoietinAlan F List, Zhuoxin Sun, Amit Verma, et al.
Leukemia & Lymphoma|June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementationCraig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma|March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemiaMolly E Graveno, Alison Carulli, Craig W Freyer, et al.
Communications Sustainability|February 12, 2026
Riparian vegetation reduces coastal turbidityHilary D Brumberg, Laura E Dee, Hikari Murayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemiaDonald E Tsai, Selina M Luger, Charalambos Andreadis, et al.
Blood Advances|May 8, 2026
Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance)Wellington F Silva, Jun Yin, Michaela Liedtke, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
American Journal of Hematology|April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agentsGee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2012
Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignanciesPrithviraj Bose, Edward B Perkins, Connie Honeycut, et al.
Pageof 32